← Leaderboards
Colin Michael Egenberger Halverson
Indiana University Indianapolis
$669,149
Attributed
$669,149
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $169.7K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$669,149 · 1
By mechanism
K01$669,149 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Sarah Elizabeth Wiehe$24,116,792
- Sharon M Moe$24,308,038
- Priscilla Anne Barnes$760,512
- Patrick C. Shih$760,512
- Yueh-Feng Yvonne Lu$3,923,858
Others in their field
Other Rising Stars on “Ethics”
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
- Michael Hogarth · University Of California, San Diego$9,228,093
- Gary Mays · Axle Informatics, Llc$9,127,422
- Frank A Provenzano · St. Joseph'S Hospital And Medical Center$8,533,907
- Cathryn Peltz · Henry Ford Health + Michigan State University Health Sciences$7,977,678
- Monica Cecilia Munoz-Torres · University Of Colorado Denver$6,821,056
Research focus
EthicsAcademyAreaEmotionalAwardAnthropologyCareerCaringAutomobile DrivingAffectCohortCommunicationCommunication ResearchComplexCoupledDangerousnessData AnalysesDesignDiagnosisDiagnosticClinical EncounterDistrustEhlers-Danlos SyndromeEvent
Grant awards (4)
Improving Care for Rare Genetic Diseases: Patient-Provider Communication and Patient Validation in the Ehlers-Danlos Syndromes$165,729
K01 · FY2025 · HG · contact PI
Improving Care for Rare Genetic Diseases: Patient-Provider Communication and Patient Validation in the Ehlers-Danlos Syndromes$164,823
K01 · FY2024 · HG · contact PI
Improving Care for Rare Genetic Diseases: Patient-Provider Communication and Patient Validation in the Ehlers-Danlos Syndromes$169,736
K01 · FY2023 · HG · contact PI
Improving Care for Rare Genetic Diseases: Patient-Provider Communication and Patient Validation in the Ehlers-Danlos Syndromes$168,861
K01 · FY2022 · HG · contact PI